467 Clinical Case. Bee Venom Anaphylaxis

نویسندگان

  • Adriana Barreto-Sosa
  • Andrea Aida Velasco-Medina
  • Andres-Leonardo Burbano-Ceron
  • Aida Gonzalez-Carsolio
  • Guillermo Velázquez-Sámano
چکیده

CAP value among the 3 groups. MANOVA multivariate analysis evaluated differences in overall CAPs and the effects of age, gender, Mueller grade and stings number. A P , 0.05 was considered statistically significant. Data were analysed by ‘SPSS’ 13.0 (SPSS Inc., Chicago, IL). We called NS patients to check if they were stung after VIT discontinuation. Results: We selected 84 NS, 72 SP3 and 76 SP5 patients. Specific YJ-IgE levels decreased during VIT, as CAPs are statistically different at time 0, 3 and 5 (P , 0.001). Considering CAP levels at the first control (CAP3), NS patients presented lower values than SP3 patients (P 1⁄4 0.002); no significant difference was found between NS and SP5 patients. At the last control (CAP5), CAP values of NS and SP5 patients were different (P 1⁄4 0.002) as well as between SP3 and SP5 patients (P 1⁄4 0.014). No significant difference was found between NS and SP3 patients. By MANOVA, IgE decrease was inversely correlated with Mueller grade (P 1⁄4 0.012) and age (P 1⁄4 0.002). We recalled all NS patients by phone, 7/84 (8.3%) patients related one well tolerated sting, as they did not develop any allergic reaction. Conclusions: In everyday practice if a patient never stung during VIT fulfils the temporal criterion, but specific IgE are not negative, a decrease of IgE levels ranging from 57 to 70% in respect to baseline might be a satisfactory parameter for stopping VIT. As a further confirmation of our conclusions, even if not statistically significant, all not stung patients were clinically protected after VIT discontinuation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.

BACKGROUND Data on outcome of insect venom immunotherapy in children are rare. OBJECTIVE We investigated the rate of sting recurrence and outcome of Hymenoptera venom anaphylaxis in children of different age groups treated with immunotherapy. METHODS Data from children consecutively referred for anaphylaxis to Hymenoptera venom were collected using a standardized questionnaire. RESULTS Du...

متن کامل

Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.

Immunotherapy is an established mode of treatment for Hymenoptera venom anaphylaxis, although adverse reactions may occur. We report the case of a 33-year-old woman, the wife of a beekeeper, who experienced a systemic allergic reaction following a bee sting. Initial specific immunotherapy had to be stopped due to anaphylaxis (multiple immediate cardiovascular reactions). We looked for an altern...

متن کامل

Risk Associated with Bee Venom Therapy: A Systematic Review and Meta-Analysis

OBJECTIVE The safety of bee venom as a therapeutic compound has been extensively studied, resulting in the identification of potential adverse events, which range from trivial skin reactions that usually resolve over several days to life-threating severe immunological responses such as anaphylaxis. In this systematic review, we provide a summary of the types and prevalence of adverse events ass...

متن کامل

Safety of 100 µg venom immunotherapy rush protocols in children compared to adults

BACKGROUND There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and adult controls. METHODS 72 consecutive cycles of VIT-buildup in 71 children/adolescents aged 7-17 years were retrospectively evaluated and compared to an adult control group (...

متن کامل

Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.

OBJECTIVE At present, no reliable in vitro test is available to monitor the success of specific venom immunotherapy (VIT) in preventing insect venom anaphylaxis. We investigated usefulness of the basophil activation test (BAT) in predicting the outcome of sting challenge in bee venom-allergic patients after VIT. PATIENTS AND METHODS Twenty-one patients with bee venom anaphylaxis at the end of...

متن کامل

In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy.

The diagnosis of insect venom allergy and the indication for specific immunotherapy is based on history, skin tests and demonstration of hymenoptera venom-specific IgE-antibodies. Cellular tests can add useful information but the role of basophil activation tests for the different venoms has to be elucidated further. We evaluated positive reactions in a basophil activation test using CD63 expre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2012